Abstract 9794: Factors Associated with Enhanced Low-Density Lipoprotein Cholesterol Lowering with Bempedoic Acid Among Patients Enrolled in Phase 3 Studies

Bempedoic acid (BA) inhibits ATP-citrate lyase in the cholesterol synthesis pathway. In phase 3 studies, 12 weeks of BA lowered low-density lipoprotein cholesterol (LDL-C) levels compared with plac...